Loading…
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (29)
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $160,270 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · fourth_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 1996 SAFE Banking Act of 2021; all provisions of the bill HR 2617 Consolidated Appropriations Act, 2023; provisions related to establishing protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers HR 3617 MORE Act of 2021; all provisions of the bill HR 4350 National Defense Authorization Act for Fiscal Year 2022; provisions related to SAFE banking HR 5657 Medical Marijuana Research Act; all provisions of the bill HR 5977 States Reform Act; all provisions of the bill S 253 Cannabidiol and Marihuana Research Expansion Act; all provisions of the bill S 4591 Cannabis Administration and Opportunity Act; all provisions of the bill Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
Client expense: $3,280,000 · Firm income: Not reported
2022 · fourth_quarter · Health Issues
Advocating for FDA dietary supplement regulation of hemp-derived CBD products: H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
H.R.841, S.1698, H.R.6645, H.R.6134 USDA Final Rule on Hemp, Growing Climate Solutions Act, SAFE banking Act, National Defense Authorization Act, other hemp regulatory matters
Client expense: Not reported · Firm income: $80,000
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
| Democratic |
| NY |
| Chellie Pingree | Democratic | ME |
| Chris Jacobs | Republican | NY |
| Dan Crenshaw | Republican | TX |
| Dan Newhouse | Republican | WA |
| David J. Trone | Democratic | MD |
| David P. Joyce | Republican | OH |
| David Scott | Democratic | GA |
| Diana DeGette | Democratic | CO |
| Dina Titus | Democratic | NV |
| Don Bacon | Republican | NE |
| Earl Blumenauer | Democratic | OR |
| Ed Perlmutter | Democratic | CO |
| Eleanor Holmes Norton | Democratic | DC |
| Gerald E. Connolly | Democratic | VA |
| Glenn Grothman | Republican | WI |
| H. Morgan Griffith | Republican | VA |
| James Comer | Republican | KY |
| Jason Crow | Democratic | CO |
| Jim Cooper | Democratic | TN |
| Jimmy Panetta | Democratic | CA |
| Joe Neguse | Democratic | CO |
| John A. Yarmuth | Democratic | KY |
| Ken Buck | Republican | CO |
| Mark Pocan | Democratic | WI |
| Matt Gaetz | Republican | FL |
| Nancy Mace | Republican | SC |
| Nanette Diaz Barragán | Democratic | CA |
| Peter A. DeFazio | Democratic | OR |
| Peter Welch | Democratic | VT |
| Ro Khanna | Democratic | CA |
| Rodney Davis | Republican | IL |
| Ron Kind | Democratic | WI |
| Ruben Gallego | Democratic | AZ |
| Salud O. Carbajal | Democratic | CA |
| Sean Patrick Maloney | Democratic | NY |
| Steve Cohen | Democratic | TN |
| Suzanne Bonamici | Democratic | OR |
| Ted Lieu | Democratic | CA |
| Tim Ryan | Democratic | OH |
| Tom Malinowski | Democratic | NJ |
| Tony Cárdenas | Democratic | CA |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Support legalization of cannabis and hemp. Support H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 841, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021. Issues related to supply chain disruptions in the beer industry.
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Issues affecting the hemp and CBD industries. H.R. 841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Education and support for public policies related to the research and development of, and access to, FDA-approved therapies containing CBD or other cannabinoids; H.R. 841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S. 4348, FDASLA Act of 2022; The Cannabis Administration and Opportunity Act (discussion draft); H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $80,000
2022 · fourth_quarter · Government Issues
HR 820 - Climb Act; all provisions of the bill HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill HR 6134 - CBD Product Safety and Standardization Act of 2021; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022 S.4591, the Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Discussions relating to regulation of the CBD industry. Discussions relating to Farm Bill Reauthorization. Discussions relating to regulation of Delta-8 THC. Monitored H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act. Monitored S. 910 Secure and Fair Enforcement (SAFE) Banking Act. Monitored executive branch nominations to federal agencies and commissions.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); S.4090, Dietary Supplement Listing Act of 2022; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
S.4348, FDASLA Act of 2022, Mandatory product registration Monitor the following: Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4090, Dietary Supplement Listing Act of 2022, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety Cosmetics Regulatory Reform related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
Monitor the following: Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Farm Bill, SNAP provisions S.4591, Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $30,000
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $178,500 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
H.R. 841, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 - monitor status of legislation H.R. 8454, the Medical Marijuana and Cannabidiol Research Expansion Act - monitor status of legislation Issues related to marijuana and CBD Farm Bill
Client expense: Not reported · Firm income: $22,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
H.R. 841, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 - monitor status of legislation Issues related to marijuana and CBD
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 1996 SAFE Banking Act of 2021; all provisions of the bill HR 3617 MORE Act of 2021; all provisions of the bill HR 4350 National Defense Authorization Act for Fiscal Year 2022; provisions related to SAFE banking HR 5657 Medical Marijuana Research Act; all provisions of the bill HR 5977 States Reform Act; all provisions of the bill S 253 Cannabidiol and Marihuana Research Expansion Act; all provisions of the bill S 4591 Cannabis Administration and Opportunity Act; all provisions of the bill Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
Client expense: $3,220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
Discussions relating to regulation of the CBD industry. Discussions relating to Farm Bill Reauthorization. Discussions relating to regulation of Delta-8 THC. Monitored H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act. Monitored S. 910 Secure and Fair Enforcement (SAFE) Banking Act. Monitored executive branch nominations to federal agencies and commissions.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · third_quarter · Health Issues
Advocating for FDA dietary supplement regulation of hemp-derived CBD products: H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
Support legalization of cannabis and hemp. Support H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Consumer Issues/Safety/Products
H.R. 841, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021. Issues related to supply chain disruptions in the beer industry.
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
H.R.841, S.1698, H.R.6645, H.R.6134 USDA Final Rule on Hemp, Growing Climate Solutions Act, SAFE banking Act, National Defense Authorization Act, other hemp regulatory matters
Client expense: Not reported · Firm income: $80,000
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Monitor the following: Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Farm Bill, SNAP provisions S.4591, Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $30,000
2022 · third_quarter · Agriculture
Issues affecting the hemp and CBD industries. H.R. 841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Consumer Issues/Safety/Products
Issues related to cannabis legalization, production, and regulation; H.R. 3617-The Marijuana Opportunity Reinvestment and Expungement Act; H.R. 841 - The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S.1698 - Hemp Access and Consumer Safety Act
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); S.4090, Dietary Supplement Listing Act of 2022; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Education and support for public policies related to the research and development of, and access to, FDA-approved therapies containing CBD or other cannabinoids; H.R. 841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S. 4348, FDASLA Act of 2022; The Cannabis Administration and Opportunity Act (discussion draft).
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4348, FDASLA Act of 2022, Mandatory product registration S.4090, Dietary Supplement Listing Act of 2022, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety Monitor the following: Over-the-counter dietary supplement products as qualified medical expenses under HSA/FSA's Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.5214, To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements, HSA/FSA supplement related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety S.2100, Personal Care Products Safety Act, Generally H.R.5747/S.1654, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, generally
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill HR 8200 - Climb Act; all provisions of the bill HR 6134 - CBD Product Safety and Standardization Act of 2021; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill S 4591 - Cannabis Administration and Opportunity Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $142,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022 S.4591, the Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Agriculture
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Agriculture
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill HR 6134 - CBD Product Safety and Standardization Act of 2021; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 1996 SAFE Banking Act of 2021; all provisions of the bill HR 3617 MORE Act of 2021; all provisions of the bill HR 4350 National Defense Authorization Act for Fiscal Year 2022; provisions related to SAFE banking HR 5657 Medical Marijuana Research Act; all provisions of the bill HR 5977 States Reform Act; all provisions of the bill S 253 Cannabidiol and Marihuana Research Expansion Act; all provisions of the bill Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
Client expense: $3,020,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
Discussions relating to regulation of the CBD industry. Discussions relating to Farm Bill Reauthorization. Discussions relating to regulation of Delta-8 THC. Monitored H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act. Monitored S. 910 Secure and Fair Enforcement (SAFE) Banking Act. Monitored executive branch nominations to federal agencies and commissions.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · second_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
Support legalization of cannabis and hemp. Support H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
Issues related to cannabis legalization, production, and regulation; H.R. 3617-The Marijuana Opportunity Reinvestment and Expungement Act; H.R. 841 - The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S.1698 - Hemp Access and Consumer Safety Act
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, Senate); H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; S.4090, Dietary Supplement Listing Act of 2022.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
H.R. 841, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021. Issues related to supply chain disruptions in the beer industry.
Client expense: $600,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
Issues affecting the hemp and CBD industries. H.R. 841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Monitor the following: Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Cannabis Legalization FARM bill, SNAP provisions
Client expense: Not reported · Firm income: $30,000
2022 · second_quarter · Health Issues
Education and support for public policies related to the research and development of, and access to, FDA-approved therapies containing CBD or other cannabinoids; H.R. 841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S. 4348, FDASLA Act of 2022; The Cannabis Administration and Opportunity Act (discussion draft).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE